Bluejay Diagnostics (BJDX) Competitors $3.52 +0.08 (+2.33%) (As of 02:19 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BJDX vs. INBS, PSTV, CUTR, BTCY, STSS, AEMD, CTCX, CHEK, POAI, and QNRXShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Intelligent Bio Solutions (INBS), Plus Therapeutics (PSTV), Cutera (CUTR), Biotricity (BTCY), Sharps Technology (STSS), Aethlon Medical (AEMD), Carmell (CTCX), Check-Cap (CHEK), Predictive Oncology (POAI), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Intelligent Bio Solutions Plus Therapeutics Cutera Biotricity Sharps Technology Aethlon Medical Carmell Check-Cap Predictive Oncology Quoin Pharmaceuticals Bluejay Diagnostics (NASDAQ:BJDX) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, community ranking, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Does the MarketBeat Community prefer BJDX or INBS? Bluejay Diagnostics received 2 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users. CompanyUnderperformOutperformBluejay DiagnosticsOutperform Votes266.67% Underperform Votes133.33% Intelligent Bio SolutionsN/AN/A Do insiders and institutionals believe in BJDX or INBS? 18.5% of Bluejay Diagnostics shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 0.4% of Bluejay Diagnostics shares are owned by insiders. Comparatively, 0.3% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is BJDX or INBS more profitable? Bluejay Diagnostics has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -288.35%. Intelligent Bio Solutions' return on equity of -147.50% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Bluejay DiagnosticsN/A -155.67% -117.82% Intelligent Bio Solutions -288.35%-147.50%-81.21% Which has more risk & volatility, BJDX or INBS? Bluejay Diagnostics has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.72, suggesting that its stock price is 372% more volatile than the S&P 500. Does the media refer more to BJDX or INBS? In the previous week, Intelligent Bio Solutions had 1 more articles in the media than Bluejay Diagnostics. MarketBeat recorded 4 mentions for Intelligent Bio Solutions and 3 mentions for Bluejay Diagnostics. Intelligent Bio Solutions' average media sentiment score of 0.67 beat Bluejay Diagnostics' score of 0.41 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bluejay Diagnostics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Intelligent Bio Solutions 0 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, BJDX or INBS? Bluejay Diagnostics has higher earnings, but lower revenue than Intelligent Bio Solutions. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBluejay Diagnostics$250K7.60-$9.95M-$1.37 thousand0.00Intelligent Bio Solutions$3.11M2.31-$10.16MN/AN/A SummaryIntelligent Bio Solutions beats Bluejay Diagnostics on 7 of the 12 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.90M$4.48B$5.10B$8.84BDividend YieldN/A36.79%5.04%4.07%P/E Ratio0.0014.3295.1214.22Price / Sales7.6044.111,217.3088.42Price / CashN/A52.2739.4936.27Price / Book0.265.836.976.37Net Income-$9.95M$13.76M$118.73M$225.56M7 Day Performance-4.86%-0.08%-1.22%-0.02%1 Month Performance-34.21%1.51%-3.07%2.04%1 Year Performance-99.72%51.75%32.52%28.00% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics1.1783 of 5 stars$3.52+2.3%N/A-99.8%$1.90M$250,000.000.009Gap DownINBSIntelligent Bio Solutions0.331 of 5 stars$1.64+17.1%N/A-61.1%$7.20M$3.11M0.0010News CoverageGap UpPSTVPlus Therapeutics3.2264 of 5 stars$1.20+0.8%$14.00+1,066.7%-37.4%$7.08M$4.91M0.0020Analyst RevisionGap UpCUTRCutera1.11 of 5 stars$0.32+5.3%$3.00+842.5%-86.7%$6.43M$212.37M-0.05430Analyst ForecastGap DownBTCYBiotricityN/A$0.28-11.1%N/A-66.9%$6.33M$12.06M-0.2340Analyst ForecastAnalyst RevisionNews CoverageSTSSSharps Technology0.7782 of 5 stars$3.43+6.2%N/AN/A$6.17MN/A-0.383Gap DownAEMDAethlon Medical2.8661 of 5 stars$0.39+1.3%$7.00+1,672.6%-77.2%$5.51M$570,000.00-0.1410CTCXCarmellN/A$0.24-2.0%N/A-90.9%$5.04MN/A0.0014CHEKCheck-Cap0.5192 of 5 stars$0.80+5.0%N/A-76.9%$4.68MN/A-0.2780Upcoming EarningsNews CoverageGap UpPOAIPredictive Oncology2.1484 of 5 stars$0.67+2.7%$3.00+347.8%-78.2%$4.47M$1.78M0.0030Analyst RevisionGap UpQNRXQuoin Pharmaceuticals2.236 of 5 stars$0.63+0.7%$4.00+534.9%-84.9%$3.18MN/A-0.164Negative NewsGap Down Related Companies and Tools Related Companies Intelligent Bio Solutions Alternatives Plus Therapeutics Alternatives Cutera Alternatives Biotricity Alternatives Sharps Technology Alternatives Aethlon Medical Alternatives Carmell Alternatives Check-Cap Alternatives Predictive Oncology Alternatives Quoin Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BJDX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
